SI1095040T1 - New benzoxazoles with pde-inhibiting activity - Google Patents

New benzoxazoles with pde-inhibiting activity

Info

Publication number
SI1095040T1
SI1095040T1 SI9930588T SI9930588T SI1095040T1 SI 1095040 T1 SI1095040 T1 SI 1095040T1 SI 9930588 T SI9930588 T SI 9930588T SI 9930588 T SI9930588 T SI 9930588T SI 1095040 T1 SI1095040 T1 SI 1095040T1
Authority
SI
Slovenia
Prior art keywords
pde
inhibiting activity
benzoxazoles
new
new benzoxazoles
Prior art date
Application number
SI9930588T
Other languages
English (en)
Slovenian (sl)
Inventor
Wolf-R�diger ULRICH
Hermann Amschler
Thomas Br
Dieter Flockerzi
Beate Schmidt
Ulrich Thibaut
Armin Hatzelmann
Hildegard Boss
Rolf Beume
Hans-Peter Kley
Dietrich H�FNER
Thomas Martin
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1095040T1 publication Critical patent/SI1095040T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9930588T 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity SI1095040T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98112469 1998-07-06
EP99931198A EP1095040B1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity
PCT/EP1999/004451 WO2000001695A1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Publications (1)

Publication Number Publication Date
SI1095040T1 true SI1095040T1 (en) 2004-10-31

Family

ID=8232222

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930588T SI1095040T1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Country Status (14)

Country Link
US (1) US6376485B1 (enExample)
EP (1) EP1095040B1 (enExample)
JP (1) JP2002519423A (enExample)
AT (1) ATE263166T1 (enExample)
AU (1) AU761647B2 (enExample)
CA (1) CA2336894A1 (enExample)
DE (1) DE69916066T2 (enExample)
DK (1) DK1095040T3 (enExample)
ES (1) ES2219031T3 (enExample)
IL (1) IL140468A0 (enExample)
PT (1) PT1095040E (enExample)
SI (1) SI1095040T1 (enExample)
WO (1) WO2000001695A1 (enExample)
ZA (1) ZA200100088B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2225215A1 (en) * 2007-11-21 2010-09-08 Decode Genetics EHF Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405633A (en) * 1982-03-01 1983-09-20 Usv Pharmaceutical Corporation Method of treatment of asthma
US4490373A (en) * 1983-05-20 1984-12-25 Usv Pharmaceutical Corporation Method of treating asthma
KR100237962B1 (ko) * 1994-10-12 2000-02-01 그린 마틴 신규한 벤즈옥사졸
DE59610031D1 (de) * 1995-05-18 2003-02-06 Altana Pharma Ag Cyclohexyldihydrobenzofurane
WO1996036624A1 (en) * 1995-05-19 1996-11-21 Kyowa Hakko Kogyo Co., Ltd. Oxygen-containing heterocyclic compounds

Also Published As

Publication number Publication date
IL140468A0 (en) 2002-02-10
DK1095040T3 (da) 2004-07-26
ZA200100088B (en) 2002-05-06
WO2000001695A1 (en) 2000-01-13
CA2336894A1 (en) 2000-01-13
ES2219031T3 (es) 2004-11-16
PT1095040E (pt) 2004-08-31
ATE263166T1 (de) 2004-04-15
AU761647B2 (en) 2003-06-05
DE69916066D1 (de) 2004-05-06
DE69916066T2 (de) 2005-02-24
JP2002519423A (ja) 2002-07-02
AU4778699A (en) 2000-01-24
US6376485B1 (en) 2002-04-23
EP1095040A1 (en) 2001-05-02
EP1095040B1 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
AU2003301020A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
YU37903A (sh) POSTUPCI LEČENJA STANJA POVEZANIH SA p38 KINAZOM I JEDINJENJA PIROLOTRIAZINA KOJA SE KORISTE KAO INHIBITORI KINAZE
YU64301A (sh) Derivati kamptotecina koji imaju antitumorno dejstvo
AU2003215753A1 (en) Imidazopyridine derivatives as kinase inhibitors
NZ505452A (en) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives and pharmaceuticals thereof, useful for inhibiting leukocyte function and treating inflammatory conditions
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
SE0202463D0 (sv) Novel compounds
PL377285A1 (pl) Podstawione pochodne pirolo-pirazolowe jako inhibitory kinazy
SI1095040T1 (en) New benzoxazoles with pde-inhibiting activity
AP2000002016A0 (en) 2-(Purin-9-yl) Tetrahydrofuran-3,4-diol derivatives.
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
GEP20084357B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
IL144026A0 (en) Phenylphenanthridine derivatives and pharmaceutical compostions containing the same
NZ527249A (en) Purine derivatives as purinergic receptor antagonists
AU5895496A (en) Phenyldihydrobenzofurans
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MY135920A (en) New phenalkyloxy-phenyl derivatives
ATE230404T1 (de) Cyclohexyldihydrobenzofurane
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
PL359409A1 (en) Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
TW200510370A (en) Urea derivatives